{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T16:49:25Z","timestamp":1784738965559,"version":"3.55.0"},"reference-count":53,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"unspecified","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute for Health and Care Research (NIHR) Midlands Patient Safety Research Collaboration"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2026,3,9]]},"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:p>Community-acquired pneumonia (CAP) is one of the most common causes of hospital admission and is associated with significant morbidity and mortality. National and international guidelines are available to guide the management of CAP, including antibiotic prescribing. However, these guidelines are often not adhered to and there is significant overprescribing of broad-spectrum antibiotics, contributing to the growing pandemic of antimicrobial resistance. Clinical Decision Support Software (CDSS) are electronic tools that use individual patient data to generate patient specific assessments or recommendations, that can then be acted on by the patient or clinical decision maker. This article reviews the evidence surrounding the initial management of CAP in hospital and considers the potential of CDSS to support CAP management.<\/jats:p>","DOI":"10.1136\/bmjresp-2024-003096","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T16:40:25Z","timestamp":1776271225000},"page":"e003096","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Personalised management of community-acquired pneumonia and the role of Clinical Decision Support Software"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2996-6711","authenticated-orcid":false,"given":"Christopher","family":"Hatton","sequence":"first","affiliation":[{"name":"Department of Inflammation and Ageing, School of Infection, Inflammation, and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, UK"},{"name":"NIHR Midlands Patient Safety Research Collaboration, University of Birmingham, Birmingham, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0596-8515","authenticated-orcid":false,"given":"Catherine","family":"Atkin","sequence":"additional","affiliation":[{"name":"Department of Inflammation and Ageing, School of Infection, Inflammation, and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1026-4125","authenticated-orcid":false,"given":"Suzy","family":"Gallier","sequence":"additional","affiliation":[{"name":"Department of Inflammation and Ageing, School of Infection, Inflammation, and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, UK"},{"name":"PIONEER Health Data Research Hub in Acute Care, Department of Research Development and Innovation, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3454-5482","authenticated-orcid":false,"given":"Elizabeth","family":"Sapey","sequence":"additional","affiliation":[{"name":"Department of Inflammation and Ageing, School of Infection, Inflammation, and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, UK"},{"name":"NIHR Midlands Patient Safety Research Collaboration, University of Birmingham, Birmingham, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"2026041509401362000_13.1.e003096.1","unstructured":"National Confidential Enquiry into Patient Outcome and Death (NCEPOD) . NCEPOD community acquired pneumonia report: consolidation required. 2023. Available: https:\/\/www.hqip.org.uk\/wp-content\/uploads\/2023\/12\/NCEPOD_community-acquired-pneumonia-report_Consolidation-Required.pdf"},{"key":"2026041509401362000_13.1.e003096.2","unstructured":"Lawrence H , Lim WS . National audit report: adult community acquired pneumonia audit 2018-2019. British Thoracic Society; 2019."},{"key":"2026041509401362000_13.1.e003096.3","unstructured":"Asthma + Lung UK analysis reveals UK has highest number of pneumonia deaths in Europe . Asthma + lung UK. 2024. Available: https:\/\/www.asthmaandlung.org.uk\/media\/press-releases\/asthma-lung-uk-analysis-reveals-uk-has-highest-number-pneumonia-deaths-europe"},{"key":"2026041509401362000_13.1.e003096.4","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2022-219925"},{"key":"2026041509401362000_13.1.e003096.5","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1080\/13696998.2022.2090734","article-title":"Hospitalization costs of adult community-acquired pneumonia in England","volume":"25","author":"Campling","year":"2022","journal-title":"J Med Econ"},{"key":"2026041509401362000_13.1.e003096.6","unstructured":"Department of Health and Social Care . NHS long term plan. London: NHS England; 2019. Available: https:\/\/www.england.nhs.uk\/publication\/the-nhs-long-term-plan\/"},{"key":"2026041509401362000_13.1.e003096.7","unstructured":"Martin A . Respiratory medicine: girft programme national specialty report. NHS England; 2021. Available: https:\/\/gettingitrightfirsttime.co.uk\/medical_specialties\/respiratory\/"},{"key":"2026041509401362000_13.1.e003096.8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s41479-017-0039-9","article-title":"Community-acquired pneumonia in the United Kingdom: a call to action","volume":"9","author":"Chalmers","year":"2017","journal-title":"Pneumonia (Nathan)"},{"key":"2026041509401362000_13.1.e003096.9","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/jamainternmed.2017.1938","article-title":"Association of Adverse Events With Antibiotic Use in Hospitalized Patients","volume":"177","author":"Tamma","year":"2017","journal-title":"JAMA Intern Med"},{"key":"2026041509401362000_13.1.e003096.10","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt477"},{"key":"2026041509401362000_13.1.e003096.11","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/jama.2019.21118","article-title":"Diagnosis and Treatment of Adults With Community-Acquired Pneumonia","volume":"323","author":"Olson","year":"2020","journal-title":"JAMA"},{"key":"2026041509401362000_13.1.e003096.12","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00735-2022","article-title":"ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of severe community-acquired pneumonia","volume":"61","author":"Martin-Loeches","year":"2023","journal-title":"Eur Respir J"},{"key":"2026041509401362000_13.1.e003096.13","doi-asserted-by":"crossref","DOI":"10.1186\/s12873-021-00505-4","article-title":"Antibiotic prescription consistent with guidelines in emergency department is associated with 30-day survival in severe community-acquired pneumonia","volume":"21","author":"Kang","year":"2021","journal-title":"BMC Emerg Med"},{"key":"2026041509401362000_13.1.e003096.14","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-206834"},{"key":"2026041509401362000_13.1.e003096.15","unstructured":"Department of Health and Social Care . Confronting antimicrobial resistance 2024 to 2029: UK 5-year action plan. London: UK Government; 2024. Available: https:\/\/www.gov.uk\/government\/publications\/uk-5-year-action-plan-for-antimicrobial-resistance-2024-to-2029\/confronting-antimicrobial-resistance-2024-to-2029"},{"key":"2026041509401362000_13.1.e003096.16","doi-asserted-by":"publisher","DOI":"10.1136\/jamia.2001.0080527"},{"key":"2026041509401362000_13.1.e003096.17","doi-asserted-by":"crossref","unstructured":"Berner ES , ed. Clinical decision support systems: Theory and practice. 2ed edn. New York, NY [Heidelberg]: Springer, 2007:269.","DOI":"10.1007\/978-0-387-38319-4_1"},{"key":"2026041509401362000_13.1.e003096.18","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2009.121434"},{"key":"2026041509401362000_13.1.e003096.19","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1996.00440130115012"},{"key":"2026041509401362000_13.1.e003096.20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2011.03672.x"},{"key":"2026041509401362000_13.1.e003096.21","unstructured":"National Institute of Health and Care Excellence (NICE). Pneumonia: diagnosis and management, 2025. Available: https:\/\/www.nice.org.uk\/guidance\/ng250"},{"key":"2026041509401362000_13.1.e003096.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2005.01.006"},{"key":"2026041509401362000_13.1.e003096.23","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00065610"},{"key":"2026041509401362000_13.1.e003096.24","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2009.133280"},{"key":"2026041509401362000_13.1.e003096.25","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00051-2023","article-title":"Outcomes of community-acquired pneumonia using the Pneumonia Severity Index versus the CURB-65 in routine practice of emergency departments","volume":"9","author":"Kaal","year":"2023","journal-title":"ERJ Open Res"},{"key":"2026041509401362000_13.1.e003096.26","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2003.008110"},{"key":"2026041509401362000_13.1.e003096.27","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm462"},{"key":"2026041509401362000_13.1.e003096.28","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2213-2600(13)70084-5","article-title":"Severity assessment scores to guide empirical use of antibiotics in community acquired pneumonia","volume":"1","author":"Singanayagam","year":"2013","journal-title":"Lancet Respir Med"},{"key":"2026041509401362000_13.1.e003096.29","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00096-2018","article-title":"Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study","volume":"4","author":"Carugati","year":"2018","journal-title":"ERJ Open Res"},{"key":"2026041509401362000_13.1.e003096.30","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2009.129502"},{"key":"2026041509401362000_13.1.e003096.31","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/S0140-6736(03)15021-0","article-title":"Community-acquired pneumonia","volume":"362","author":"File","year":"2003","journal-title":"The Lancet"},{"key":"2026041509401362000_13.1.e003096.32","unstructured":"UK Health Security Agency . ESPAUR report 2023-2024: english surveillance programme for antimicrobial utilisation and resistance. 2024. Available: https:\/\/assets.publishing.service.gov.uk\/media\/6734e208b613efc3f1823095\/ESPAUR-report-2023-2024.pdf"},{"key":"2026041509401362000_13.1.e003096.33","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.12.0723"},{"key":"2026041509401362000_13.1.e003096.34","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2334-13-268","article-title":"A risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumonia","volume":"13","author":"Shorr","year":"2013","journal-title":"BMC Infect Dis"},{"key":"2026041509401362000_13.1.e003096.35","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03071-15"},{"key":"2026041509401362000_13.1.e003096.36","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.168.20.2205"},{"key":"2026041509401362000_13.1.e003096.37","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201301-0079OC"},{"key":"2026041509401362000_13.1.e003096.38","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/CPM.0000000000000101","article-title":"The PES (Pseudomonas, Enterobacteriaceae ESBL, Methicillin-resistant Staphylococcus aureus) Concept in Community-acquired Pneumonia","volume":"22","author":"Prina","year":"2015","journal-title":"Clin Pulm Med"},{"key":"2026041509401362000_13.1.e003096.39","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1001\/jama.2024.6248","article-title":"Stewardship Prompts to Improve Antibiotic Selection for Pneumonia: The INSPIRE Randomized Clinical Trial","volume":"331","author":"Gohil","year":"2024","journal-title":"JAMA"},{"key":"2026041509401362000_13.1.e003096.40","unstructured":"Medicines and Healthcare products Regulatory Agency (MHRA) . Fluoroquinolone antibiotics: must now only be prescribed when other commonly recommended antibiotics are inappropriate - GOV.UK. 2024. Available: https:\/\/www.gov.uk\/drug-safety-update\/fluoroquinolone-antibiotics-must-now-only-be-prescribed-when-other-commonly-recommended-antibiotics-are-inappropriate"},{"key":"2026041509401362000_13.1.e003096.41","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00824-2019","article-title":"Macrolide combination therapy for patients hospitalised with community-acquired pneumonia? An individualised approach supported by machine learning","volume":"54","author":"K\u00f6nig","year":"2019","journal-title":"Eur Respir J"},{"key":"2026041509401362000_13.1.e003096.42","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1164\/rccm.202109-2092OC","article-title":"A Pragmatic, Stepped-Wedge, Cluster-controlled Clinical Trial of Real-Time Pneumonia Clinical Decision Support","volume":"205","author":"Dean","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2026041509401362000_13.1.e003096.43","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1097\/CCM.0000000000006163","article-title":"ICU Utilization After Implementation of Minor Severe Pneumonia Criteria in Real-Time Electronic Clinical Decision Support","volume":"52","author":"Carr","year":"2024","journal-title":"Crit Care Med"},{"key":"2026041509401362000_13.1.e003096.44","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6947-8-35","article-title":"Improving antibiotic prescribing for adults with community acquired pneumonia: Does a computerised decision support system achieve more than academic detailing alone?--A time series analysis","volume":"8","author":"Buising","year":"2008","journal-title":"BMC Med Inform Decis Mak"},{"key":"2026041509401362000_13.1.e003096.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2019.04.093"},{"key":"2026041509401362000_13.1.e003096.46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2215145"},{"key":"2026041509401362000_13.1.e003096.47","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00489-2021","article-title":"Community-acquired pneumonia subgroups and differential response to corticosteroids: a secondary analysis of controlled studies","volume":"8","author":"Wittermans","year":"2022","journal-title":"ERJ Open Res"},{"key":"2026041509401362000_13.1.e003096.48","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02902-1"},{"key":"2026041509401362000_13.1.e003096.49","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.clinthera.2019.01.018","article-title":"Computerized Clinical Decision Support Systems and Antibiotic Prescribing: A Systematic Review and Meta-analysis","volume":"41","author":"Carracedo-Martinez","year":"2019","journal-title":"Clin Ther"},{"key":"2026041509401362000_13.1.e003096.50","doi-asserted-by":"crossref","DOI":"10.1038\/s41746-020-0221-y","article-title":"An overview of clinical decision support systems: benefits, risks, and strategies for success","volume":"3","author":"Sutton","year":"2020","journal-title":"NPJ Digit Med"},{"key":"2026041509401362000_13.1.e003096.51","unstructured":"Ash JS , Sittig DF , Campbell EM , et al . Some Unintended Consequences of Clinical Decision Support Systems. AMIA Annu Symp Proc 2007;26\u201330."},{"key":"2026041509401362000_13.1.e003096.52","unstructured":"Electronic patient records: why the nhs urgently needs a strategy to reap the benefits - the health foundation. 2025. Available: https:\/\/www.health.org.uk\/reports-and-analysis\/analysis\/electronic-patient-records-nhs-strategy"},{"key":"2026041509401362000_13.1.e003096.53","doi-asserted-by":"publisher","DOI":"10.1016\/S2589-7500(20)30317-4"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2024-003096","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T16:40:31Z","timestamp":1776271231000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2024-003096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,4,15]]},"published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1136\/bmjresp-2024-003096"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2024-003096","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]}}}